What are ADCs and how do they work against cancer?

March 6, 2024 Julie Luong

Antibody-drug conjugates (ADCs) are a promising avenue for precision cancer treatments.

In this short animated video, learn the basics of how ADCs are engineered and why that makes them such powerful tools to target cancers with precision.

Dive deeper into the topic of ADC development and the bioconjugation process with further resources:

Previous Video
Virtual Monolith X Demo: Free-in-solution affinity measurements with minimal sample consumption​
Virtual Monolith X Demo: Free-in-solution affinity measurements with minimal sample consumption​

The tool you choose to measure affinities should tackle a diverse range of targets and ligands that come yo...

Up next
Screening for p38 ligands: From assay optimization to lead validation in 2 days
Screening for p38 ligands: From assay optimization to lead validation in 2 days

Dianthus is a biophysical screening instrument that uses Spectral Shift technology to measure molecular int...